PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Covance Inc.
(NYSE: CVD) today announced that it has elected Dr. Gary E. Costley to its
Board of Directors.
Dr. Costley adds further executive management experience to the Covance
Board of Directors, as well as extensive scientific depth in nutritional
chemistry, food safety and drug discovery services. He was Chairman and Chief
Executive Officer of International Multifoods Corporation, manufacturer of
branded consumer food and foodservice products. He also spent 25 years at the
Kellogg Company in roles of increasing global responsibility in the areas of
nutrition research and product development, public affairs and executive
management. Dr. Costley is a co-founder and currently managing director of C&G
Capital Management, LLC, which provides capital and management to health,
medical and nutritional products and services companies.
Dr. Costley is a board member for three other public companies: Prestige
Brand Holdings, Inc., a company that develops and markets over-the-counter
drugs, household cleaning products and personal care items; Principal
Financial Group, Inc., a financial and asset management company; and Tiffany
and Co., a holding company for Tiffany and Company, a jewelry and specialty
retailer. He also previously held board memberships in Accelrys, Inc. and
Pharmacopeia Drug Discovery, Inc., organizations specializing in products and
services that improve and accelerate drug discovery and chemical development.
"I am very pleased to welcome Dr. Gary Costley to the Covance Board of
Directors. Dr. Costley's successful track record in leading global public
companies brings tremendous value to Covance's board," said Joe Herring,
Covance Chairman and Chief Executive Officer. "His strong scientific
background in food product development and nutrition research will also
enhance Covance's ability to respond to the increasing global demand for food
Dr. Costley earned a B.S. in animal science, and a M.S. and Ph.D. in
Nutrition, with minors in Physiology and Biochemistry from Oregon State
Covance, with headquarters in Princeton, New Jersey, is one of the world's
largest and most comprehensive drug development services companies with annual
revenues greater than $1.3 billion, global operations in more than 20
countries, and more than 8,400 employees worldwide. Information on Covance's
products and services, recent press releases, and SEC filings can be obtained
through its website at http://www.covance.com.